XHKG
2138
Market cap82mUSD
Oct 09, Last price
0.52HKD
1D
-5.45%
1Q
38.67%
Jan 2017
-81.43%
IPO
-82.67%
Name
EC Healthcare
Chart & performance
P/E
—
P/S
0.16
EPS
—
Div yield, %
—
Shrs. gr., 5y
2.82%
Rev. gr., 5y
12.63%
Revenues
3.77b
-8.94%
Net income
-403m
L+140.88%
CFO
607m
-18.39%
Dividend
Dec 30, 20240.01 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
EC Healthcare, an investment holding firm, delivers an extensive range of medical and healthcare services throughout Hong Kong, Macau, and mainland China. Its operations are structured into three primary divisions: Medical, Aesthetic Medical and Beauty and Wellness, and an 'Others' category. The company's diverse service offerings include quasi-medical treatments, beauty and wellness programs, medical imaging, surgical procedures, aesthetic medicine, dentistry, hair restoration, vaccinations, chiropractic care, psychological support, and orthopedic services. Beyond direct patient care, EC Healthcare also provides administrative and management support, laboratory diagnostics, various marketing and performance marketing solutions, and even travel agency services. Furthermore, it retails beauty and skincare products, manages healthcare machinery, engages in property investment, offers multi-channel networking, and extends its expertise to veterinary services. Its product and service portfolio is primarily marketed under proprietary brands such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. Established in 2005 and headquartered in Mong Kok, Hong Kong, the company was formerly known as Union Medical Healthcare Limited before rebranding to EC Healthcare in April 2021.
Key people
Chi Fai Tang
Executive Chairman of the Board, Chief Executive Officer · since 2015
Chief Operating Officer, Executive Director · since 2015
Yeung Cheng
General Manager - Medical Operations · since 2015
Chi Cheung Wong
Executive Director · since 2020
Company Secretary · since 2017
Kun Shing Ben Luk
Non-Executive Director · since 2018
Chi Hang Lam
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2016
Non-Executive Independent Director · since 2016
Legal address
Cricket Square
Hutchins Drive
P.O. Box 2681
Grand Cayman KY1-1111
KY
Hutchins Drive
P.O. Box 2681
Grand Cayman KY1-1111
KY
Headquarters
Flat/RM 7-9, Level 21
Langham Place Office Tower
8 Argyle Street Mongkok
Hong Kong
HK
Langham Place Office Tower
8 Argyle Street Mongkok
Hong Kong
HK
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||